Tag: ImaginAbs
New analysis of Phase II data at AACR assesses ImaginAb’s investigational...
LOS ANGELES, April 14, 2023 /PRNewswire/ -- ImaginAb Inc., a global biotechnology company developing 89Zr crefmirlimab berdoxam (CD8 ImmunoPET™) imaging agent and radiopharmaceutical...